ZITUVIMET (Sitagliptin and Metformin Hydrochloride) — NDC 70710-1787 by Zydus Pharmaceuticals (USA) Inc.
ZITUVIMET (Sitagliptin and Metformin Hydrochloride) — NDC 70710-1787 by Zydus Pharmaceuticals (USA) Inc. is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: ZITUVIMET; Generic name: Sitagliptin and Metformin Hydrochloride; Product NDC: 70710-1787.
| Brand name | ZITUVIMET |
|---|---|
| Generic name | Sitagliptin and Metformin Hydrochloride |
| Product NDC | 70710-1787 |
| Labeler | Zydus Pharmaceuticals (USA) Inc. |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | METFORMIN HYDROCHLORIDE 1000 mg/1; SITAGLIPTIN 50 mg/1 |
| Pharmacologic class | Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →